Therapeutic nucleus-access BNCT drug combined CD47-targeting gene editing in glioblastoma

Glioblastoma is the most common brain primary malignant tumor with the highest mortality. Boron neutron capture therapy (BNCT) can efficiently kill cancer cells on the cellular scale, with high accuracy, short course and low side-effects, which is regarded as the most promising therapy for malignant...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiejian, Dai, Qi, Yang, QiYao, Bao, Xiaoyan, Zhou, Yi, Zhong, Haiqing, Wu, Linjie, Wang, Tiantian, Zhang, Zhicheng, Lu, Yiying, Zhang, Zhentao, Lin, Mengting, Han, Min, Wei, Qichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895533/
https://www.ncbi.nlm.nih.gov/pubmed/35246144
http://dx.doi.org/10.1186/s12951-022-01304-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895533/
https://www.ncbi.nlm.nih.gov/pubmed/35246144
http://dx.doi.org/10.1186/s12951-022-01304-0

Ejemplares similares